New lower pricing. Same products. Same testing standards. Free U.S. shipping over $100.

SLU-PP-332 Research Compound (10mg)

$82.00

SLU-PP-332 is a synthetic small-molecule research compound studied in preclinical estrogen-related receptor (ERR) models. Review batch documentation and the research-context guide before evaluating material for a defined laboratory application.

For research use only. Not for human or veterinary use.

Free U.S. shipping on $100+
COA Available Batch Documented HPLC Verified

Out of Stock

Ordering is temporarily paused.
Notify me when ordering resumes

Overview

SLU-PP-332 is a synthetic small-molecule research compound studied as an agonist of estrogen-related receptors ERRα, ERRβ, and ERRγ. It is not a peptide.

For research use only. Not for human or veterinary use.

Research Context

Published preclinical work examines receptor-associated activity, gene-expression responses, and cellular respiration in defined experimental models. These findings do not establish performance of a current product batch or clinical outcomes.

Review the SLU-PP-332 Research Context guide for primary references, model distinctions, and evidence boundaries.

Analytical Verification

Match the lot identifier to the relevant certificate and review the intended compound identity, sample information, analytical methods, test dates, and reported results. Identity, chromatographic purity, and quantitative content answer different questions.

Review Testing & Verification and the certificate review guide. Analytical documentation alone does not establish biological activity, sterility, endotoxin status, or suitability for a particular assay.

Research Documentation

SLU-PP-332 belongs to a different chemical and receptor framework from peptide materials. See the Research Library for evidence-led compound and documentation resources.

Testing & Verification

Each batch supplied by Not Labs undergoes independent analytical testing to verify compound identity, purity, and integrity. Batch-specific Certificates of Analysis (COAs) are provided for transparency and research verification purposes.

Where applicable, purity specifications (≥99%) are indicated on product labeling and corresponding COA documentation.

SLU-PP-332 10mg COA certificate of analysis for research compound purity

 

Research FAQ

1. What type of compound is SLU-PP-332 in research settings?
SLU-PP-332 is an investigational peptide studied in early-stage laboratory research to characterize metabolic signaling and regulatory pathway interactions.

2. Is SLU-PP-332 a well-established research compound?
SLU-PP-332 is considered a newer, exploratory compound primarily evaluated in foundational preclinical studies.

3. What research areas commonly utilize SLU-PP-332?
Laboratory research includes early-phase metabolic signaling investigation, peptide characterization studies, and comparative pathway analysis.

4. How should SLU-PP-332 be stored for laboratory research?
Lyophilized SLU-PP-332 is typically stored at −20 °C. After reconstitution, aliquoting and refrigerated storage are commonly used to support experimental stability.

Scientific References

  1. Billon C, Sitaula S, Banerjee S, et al. Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. ACS Chemical Biology.
    https://pubmed.ncbi.nlm.nih.gov/36988910/

  2. Billon C, Schoepke E, Avdagic A, et al. A Synthetic ERR Agonist Alleviates Metabolic Syndrome. Journal of Pharmacology and Experimental Therapeutics.
    https://pubmed.ncbi.nlm.nih.gov/37739806/

  3. Xu W, Billon C, Li H, et al. Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function. Circulation.
    https://pubmed.ncbi.nlm.nih.gov/37961903/

  4. Wang XX, Myakala K, Libby AE, et al. Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney. The American Journal of Pathology.
    https://pubmed.ncbi.nlm.nih.gov/37717940/

  5. Bonanni R, Falvino A, Matticari A, et al. Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study. Frontiers in Physiology.
    https://pubmed.ncbi.nlm.nih.gov/40692696/

JOIN THE NOT LABS RESEARCH LIST

Get updates on new compound releases, research insights, and subscriber offers.

New Lower Pricing. Same Products & Protocol.

10% off your first order upon confirmation.